Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jiayue Jin

Biographic Data

ID7279893
NAMEJiayue Jin
GIVEN NAMESJiayue
FAMILY NAMEJin
SIGNATUREJIN J
AFFILIATIONSChinese Academy of Medical Sciences & Peking Union Medical College
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2024
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Long-term symptom burden in a young, ambulatory cohort after the omicron outbreak in China

    Open Access•Simeng Ren, Yumeng Tan et al.•ARTICLE•Frontiers in Public Health•2025

    Introduction At the end of 2022, an outbreak of the Omicron BF.7 and BA.5.2 subvariants of SARS-CoV-2 occurred in China. In this prospective cohort study, we investigated the pattern of development of major symptom burden and influencing factors in infected Chinese patients. Methods First-time infected outpatients were enrolled from December 7, 2022, to January 11, 2023 ( N = 355). The prevalence of symptoms was monitored by a repeated patient-re…

  • Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials

    Open Access•Ning Ma, Bei Pan et al.•ARTICLE•Journal of Ethnopharmacology•2025

  • Traditional Chinese medicine for insomnia: Recommendation mapping of the global clinical guidelines

    Open Access•Ziying Ye, Honghao Lai et al.•ARTICLE•Journal of Ethnopharmacology•2024

No prominent works on this page.

  • Traditional Chinese medicine for insomnia: Recommendation mapping of the global clinical guidelines

    Open Access•Ziying Ye, Honghao Lai et al.•ARTICLE•Journal of Ethnopharmacology•2024

  • Long-term symptom burden in a young, ambulatory cohort after the omicron outbreak in China

    Open Access•Simeng Ren, Yumeng Tan et al.•ARTICLE•Frontiers in Public Health•2025

    Introduction At the end of 2022, an outbreak of the Omicron BF.7 and BA.5.2 subvariants of SARS-CoV-2 occurred in China. In this prospective cohort study, we investigated the pattern of development of major symptom burden and influencing factors in infected Chinese patients. Methods First-time infected outpatients were enrolled from December 7, 2022, to January 11, 2023 ( N = 355). The prevalence of symptoms was monitored by a repeated patient-re…

  • Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials

    Open Access•Ning Ma, Bei Pan et al.•ARTICLE•Journal of Ethnopharmacology•2025

Alternative medicine (1 works) · Ambulatory (1 works) · Ambulatory care (1 works) · China (1 works) · Cohort (1 works) · Cohort study (1 works) · Computer Science (1 works) · COVID-19 and Mental Health (1 works) · Evidence-based medicine (1 works) · Excellence (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae